Vimarsana
Biggest News Aggregation in the World

Resolution Mapping News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resolution Mapping. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resolution Mapping Today - Breaking & Trending Today

DNA methylation: A key player in gene expression variation and disease manifestation - Vimarsana News

DNA methylation: A key player in gene expression variation and disease manifestation

Professor Asaf Hellman and his research team at the Hebrew University-Hadassah Medical School have unveiled new findings in the realm of methylation-directed regulatory networks.

Geologist: How Geologic Factors Generate El Nino And La Nina Events - Vimarsana News

Geologist: How Geologic Factors Generate El Nino And La Nina Events

This research presents convincing evidence that geological activity is behind the generation of El Ninos and La Ninas.

Innovative Health Receives Clearance to Reprocess INTELLAMAP ORION High-Resolution Mapping Catheter - Vimarsana News

Innovative Health Receives Clearance to Reprocess INTELLAMAP ORION High-Resolution Mapping Catheter

Clearance adds important savings for Innovative Health's partner hospitals

Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection - Vimarsana News

Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection

1 Abstract The devastating Ebola outbreak in West Africa in 2013-2016 accelerated the progress of several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several IPs were used during that outbreak, but no conclusion on efficacy could be drawn. Only the Randomized Controlled Trial (RCT) on ZMapp was promising but inconclusive. More recently, during the second largest Ebola outbreak in North Kivu and Ituri provinces, Democratic Republic of the Congo (DRC), four IPs (Remdesivir, Regeneron, ZMapp and MAb114) have been evaluated in a RCT, the Pamoja Tulinde Maisha (PALM) study. Tw...